CompletedPhase 2ketamine

Nasal Administration of Sufentanil+Ketamine for Procedure-related Pain in Children

NCT ID

NCT01047241

Target Enrollment

50 participants

Start Date

2010-04

Est. Completion

2013-02

About This Study

The aim of the study is to investigate the absorption and clinical effect of nasal administration of an analgesic nasal spray containing sufentanil+ketamine for pain related to medical procedures in hospitalized children.

Conditions Studied

Pain

Interventions

•Intranasal sufentanil/ketamine

Eligibility

Age:1 Year - 19 Years

Healthy Volunteers:No

View full eligibility criteria

Inclusion Criteria:

* Children and adolescents treated at the University Hospital, Rigshospital
* Painful medical procedure related to the patients treatment
* Patient and/or the parents must be able to understand and speak danish
* Negative pregnancy test for girls, when relevant
* Signed informed consent
* Only a light meals or no meals have been ingested 2 hours prior to inclusion

Exclusion Criteria:

* Allergy to sufentanil or ketamine
* Abnormal nasal cavity
* Have been treated with sufentanil and/or ketamine during the last 48 hours
* Nasal obstruction (rhinitis)

Study Locations (1)

Copenhagen University Hospital Rigshospitalet

Copenhagen, Denmark